Abstracts

Citation

Mark Mirochnick, M.D., Alejandro Dorenbaum, M.D., Bethann Cunningham-Schrader, B.A., M.S., Coleen K. Cunningham, M.D., Richard D. Gelber, Ph.D., Lynne M. Mofenson, M.D., F.A.A.P., John L. Sullivan, M.D. Cord blood protease inhibitor (PI) concentrations in infants born to mothers receiving PI's. Presented at: 8th Conference on Retroviruses & Opportunistic Infections.

Citation

CM Dugdale, SR Permar, L Stranix-Chibanda, RP Walensky, GG Fouda, L Myer, CK Cunningham, MC Weinstein, V Leroy, EJ McFarland, KA Freedberg, AL Ciaranello. Cost-effectiveness of broadly neutralizing antibodies for infant HIV prophylaxis. Presented at: CROI 2020.

Citation

Donald Campbell, Ph.D., Nancy Tustin, M.L.T., (ASCP), Eric Riedel, B.S., Richard Tustin, III, J. Taylor, Steven D. Douglas, M.D. Cryopreservation Decreases PD-1/PD-L1 Co-Inhibitory Expression on PBMC-Derived T Cells and Monocytes. Presented at: 16th Conference on Retroviruses & Opportunistic Infections.

Citation

Kumud K. Singh, Michael Hughes, Ph.D., Jie (Ellen) Chen, M.S., Kelesitse Phiri, C. Rousseau, Louise Kuhn, Beverly A. Jackson, R.N., R. Semba, Stephen A. Spector, M.D. CX3CR1-249 polymorphism is important determinant of risk of perinatal transmission of HIV-1 in African children. Presented at: 12th Conference on Retroviruses and Opportunistic Infections.

Citation

Akihiko Saitoh, M.D., Elizabeth Sarles, Edmund Capparelli, Pharm.D., Francesca Aweeka, Pharm.D., Andrea Kovacs, M.D., Sandra K. Burchett, M.D., M.S., Andrew A. Wiznia, M.D., Sharon Appelbaum Nachman, M.D., Terence Fenton, Ed.D., Stephen A. Spector, M.D. CYP2B6-G516T genetic variants affect the pharmacokinetics of nevirapine and clinical responses in HIV-1 infected children receiving HAART. Presented at: 14th Conference on Retroviruses and Opportunistic Infections.

Citation

Akihiko Saitoh, M.D., Courtney V. Fletcher, Pharm.D., Richard Brundage, Pharm.D., Ph.D., Terence Fenton, Ed.D., Carmelita Alvero, Stephen A. Spector, M.D. CYP2B6-G516T polymorphisms influence plasma concentrations of efavirenz in HIV-1 infected children receiving HAART. Presented at: 13th Conference on Retroviruses and Opportunistic Infections.

Citation

Akihiko Saitoh, M.D., Elizabeth Sarles, Edmund Capparelli, Pharm.D., Francesca Aweeka, Pharm.D., Andrea Kovacs, M.D., Sandra K. Burchett, M.D., M.S., Andrew A. Wiznia, M.D., Sharon Appelbaum Nachman, M.D., Terence Fenton, Ed.D., Stephen A. Spector, M.D. CYP2C19 genetic variants affect nelfinavir and M8 pharmacokinetics and virologic response in HIV-1 infected children receiving HAART. Presented at: 15th Conference on Retroviruses & Opportunistic Infections.

Citation

Zixuan Wei, Mary Morrow, Samantha MaWhinney, Amita Gupta, Adriana Weinberg, Grace Montepiedra, Avy Violari, Gerhard Theron, Ponego L. Ponatshego, Gaerolwe Masheto, Anneke C. Hesseling, Peter L. Anderson, Kristina M. Brooks, IMPAACT P1078 Study Team. Cytokines in pregnant and postpartum women with HIV and latent TB: results from IMPAACT P1078. Presented at: CROI 2026; 2026 Feb 24.

Citation

Daily Infant Nevirapine (NVP) through Six-months of Life for Prevention of Mother-to-Child Transmission of HIV-1 (PMTCT) - Adherence and NVP Exposure (HPTN 046 Trial). Presented at: 20th Conference on Retroviruses and Opportunistic Infections.

Citation

Priyanka Uprety, Kaitlin Rainwater-Lovett, Ellen G. Chadwick, Edmund V. Capparelli, Carrie Ziemniak, Katherine Luzuriaga, Larry Moulton, Deborah Persaud. Decay Rate and HIV-1 DNA Reservoir Size Following Early Infant Antiretroviral Therapy. Presented at: CROI 2015; 2015 Feb 25.